Revolution Medicines Statistics
NASDAQ: RVMDHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
185.46-15.41 (-7.67%)
Market open · Delayed 15 min · as of Oct 8, 1:57 PM ET
Revolution Medicines by the numbers
Revolution Medicines has a market capitalization of $39.75 billion based on 214.34M shares outstanding. With trailing EPS of $-8.87, Revolution Medicines is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.8% below its 50-day average and 25.5% above its 200-day average.
Average daily trading volume is 1.88M shares, or about $349.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RVMD valuation vs. peer median
| Metric | RVMD | Peer median | Difference |
|---|---|---|---|
| Market cap | $39.75B | $14.60B | +172% |
| Avg. volume | 1.88M | 1.73M | +9% |
Peer median across 8 companies: ARGX, BIIB, BNTX, EXEL, NBIX, HALO, TECH, IBRX.
Valuation
- Market cap
- $39.75B
- EPS (TTM)
- $-8.87
- Shares outstanding
- 214.34M
Price and trading
- Previous close
- 200.87
- Open
- 198.51
- Day range
- 180.52 – 199.64
- 52-week range
- 47.28 – 224.31
- 52-week change
- +331.33%
- 50-day moving average
- 203.33
- 200-day moving average
- 147.82
- Beta
- —
- Volume
- 3.37M
- Average volume
- 1.88M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 39.75B
- Forward Pe
- -32.48
- Eps
- -8.87
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 224.31
- Week52 Low
- 47.28
- Avg Volume
- 1.88M
- Shares Outstanding
- 214.34M
- Ma50
- 203.33
- Ma200
- 147.82
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -17.32%
- Pct From52w Low
- 292.26%